Vimarsana
Biggest News Aggregation in the World

Ergogenic Aids News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ergogenic Aids. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ergogenic Aids Today - Breaking & Trending Today

ADHD Drug Shortage Forces More Parents To Beat Their Kids - Vimarsana News

ADHD Drug Shortage Forces More Parents To Beat Their Kids

SILVER SPRING, MD—Amid a shortage caused by rising demand, manufacturing issues, and federal limits on production, the Food and Drug Administration confirmed Friday that the inadequate supply of ADHD drugs was forcing more parents to beat their children. “Faced with out-of-stock pharmacies and few viable alternatives,…

ADHD medication shortage threatens routine for millions of kids and adults, says local pharmacist - Vimarsana News

ADHD medication shortage threatens routine for millions of kids and adults, says local pharmacist

October is recognized as Attention Deficit Hyperactivity Disorder Awareness Month, but there are some roadblocks in treatment due to nationwide supply and deman

Source: wtov9.com
What To Know About Shortages Of Adderall, Ozempic, And Other Medicines - Vimarsana News

What To Know About Shortages Of Adderall, Ozempic, And Other Medicines

Mounting shortages of medications like the ADHD treatment Adderall and the diabetes and weight-loss drug Ozempic have caused anxiety among patients who rely on them, with experts attributing the scarcity to multiple factors. The Onion tells you everything you need to know about the ongoing shortages of these…

Is Adderall shortage due to telehealth prescriptions? — Quartz - Vimarsana News

Is Adderall shortage due to telehealth prescriptions? — Quartz

Overprescription caused shortages of Adderall and other amphetamines

Source: qz.com
Glenmark Pharma gets USFDA nod for amphetamine sulfate tablets - Vimarsana News

Glenmark Pharma gets USFDA nod for amphetamine sulfate tablets

The drug maker on Thursday announced that it has received final approval by the US drug regulator for amphetamine sulfate tablets.The drug is generic version of Evekeo tablets of Arbor Pharmaceuticals. According to IQVIA sales data for the 12-month period ending November 2020, the Evekeo Tablets, achieved annual sales of approximately $21.5 million. Amphetamine sulfate tablets are used to treat attention-deficit hyperactivity disorder (ADHD) and a sleep disorder called narcolepsy. It is also used as a short-term treatment, along with a reduced calorie diet and exercise, to help lose weight. ...